Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of IXJ's 113 holdings also in
nan%
% of 's holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus )
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to
 |
ELI LILLY & CO | 9.1% |
|
JOHNSON & JOHNSON | 5.3% |
|
UNITEDHEALTH GROUP INC | 5.1% |
|
ABBVIE INC | 4.8% |
 |
ROCHE HOLDING LTD | 3.2% |
|
ABBOTT LABORATORIES | 3.2% |
|
NOVARTIS AG | 3.1% |
 |
ASTRAZENECA PLC | 3.1% |
 |
NOVO NORDISK A/S-B | 3.1% |
|
MERCK & CO. INC. | 2.9% |
IXJ Underweight Relative to
 |
GRIFOLS, S.A. CLASS A | 0.0% |
 |
GETINGE AB-B SHS | 0.1% |
|
ZEALAND PHARMA A/S | 0.1% |
 |
SO-NET M3 INC | 0.1% |
|
ONO PHARMACEUTICAL CO LTD | 0.1% |
 |
REDE D'OR SAO LUIZ SA | 0.1% |
|
CHARLES RIVER LABORATORIES | 0.1% |
 |
SARTORIUS STEDIM BIOTECH SA | 0.1% |
 |
SARTORIUS AG PREF | 0.1% |
|
DAVITA INC | 0.1% |